Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Is DHEA-S primarily an adrenal androgen precursor?

DHEA-S is primarily an adrenal androgen precursor, and lower age-adjusted levels can reflect reduced adrenal androgen precursor reserve.

PlausibleAugust 21, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

DHEA-S is primarily an adrenal androgen precursor, and lower DHEA-S reflects reduced adrenal androgen precursor reserve

laying out figure…
0 of 3 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says DHEA-S mainly comes from the adrenal cortex and serves as a circulating reserve for local androgen formation. The conclusion frames a low result as consistent with reduced adrenal precursor output, while noting that aging and glucocorticoid exposure can also lower levels. It also implies that interpretation depends on age and clinical context rather than a single value alone.

Verified conclusion

DHEA-S is a long-lived circulating sulfated steroid that is highly informative about adrenal androgen biology, but its clinical interpretation is strongly age- and context-dependent—particularly in a 71-year-old man.

Adrenal origin and androgen-precursor role

  • DHEA-S is produced predominantly in the adrenal-cortical zona reticularis. High reticularis expression of cytochrome b5 (CYB5A) and sulfotransferase 2A1 (SULT2A1), with relatively low HSD3B2, favors conversion of DHEA into DHEA-S.
  • It functions chiefly as a circulating reservoir for local (“intracrine”) androgen formation rather than as a potent androgen itself. Steroid sulfatase in peripheral tissues regenerates DHEA; 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase can subsequently form androstenedione and testosterone intracellularly.

Meaning of a low result

  • A low DHEA-S is plausibly consistent with lower adrenal androgen-precursor output. Aging is a major biological explanation: declining zona-reticularis function, CYP17A1 activity, and ACTH responsiveness reduce production after early adulthood, often by 2–5% annually. By age 70–80, concentrations may be only 10–20% of young-adult peak values (“adrenopause”).
  • Therefore, in this patient, a value that is low relative to the laboratory’s male, age-specific reference range can support reduced adrenal androgen precursor reserve, but may still represent expected age-related physiology.

Clinical interpretation

  • Illness, inflammation, chronic stress or hospitalization, and ACTH-suppressing glucocorticoids—especially dexamethasone—can lower DHEA-S independent of intrinsic adrenal failure. Phenytoin and carbamazepine may also lower steroid concentrations through altered metabolism.
  • DHEA-S alone does not establish generalized adrenal reserve or adrenal insufficiency; suspected insufficiency is assessed with morning cortisol and ACTH, with cosyntropin stimulation when indicated.

Bottom line

  • The claim is substantially correct: DHEA-S is primarily an adrenal androgen precursor, and unexpectedly low age-adjusted concentrations support—but do not prove—reduced adrenal androgen precursor reserve.

References

  1. Regulation of the Adrenal Androgen Biosynthesis - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  2. The zona reticularis is the site of biosynthesis of ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  3. Adrenal androgens and androgen precursors: definition, synthesis ... — pmc.ncbi.nlm.nih.gov ↗
  4. Adrenal Androgens and Aging - Endotext - NCBI Bookshelf - NIH — ncbi.nlm.nih.gov ↗
  5. Dehydroepiandrosterone Secretion in Healthy Older Men and Women — pmc.ncbi.nlm.nih.gov ↗
  6. Neurobiological and Neuropsychiatric Effects of ... - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  7. The influence of hormones and pharmaceutical agents on DHEA ... — pure.johnshopkins.edu ↗
  8. Intracrine androgen biosynthesis, metabolism and action ... — pmc.ncbi.nlm.nih.gov ↗
  9. Steroid sulfatase stimulates intracrine androgen synthesis and is a ... — pmc.ncbi.nlm.nih.gov ↗
  10. Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue — joe.bioscientifica.com ↗
  11. Adrenal Aging and Its Implications on Stress Responsiveness ... - PMC — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→